赛马鲁肽
医学
内科学
糖尿病
2型糖尿病
心脏病学
利拉鲁肽
内分泌学
作者
Mansoor Husain,Andreas L. Birkenfeld,Morten Donsmark,Kathleen Dungan,Freddy G. Eliaschewitz,Denise Reis Franco,Ole Kleist Jeppesen,Ildiko Lingvay,Ofri Mosenzon,Sue D. Pedersen,Cees J. Tack,Mette S. Thomsen,Tina Vilsbøll,Mark Warren,Stephen C. Bain
标识
DOI：10.1056/nejmoa1901118
摘要
Establishing cardiovascular safety of new therapies for type 2 diabetes is important. Safety data are available for the subcutaneous form of the glucagon-like peptide-1 receptor agonist semaglutide but are needed for oral semaglutide.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
OK
GingerF
FIN
斯文的白玉
Criminology34
无极微光
归零者
XX
秋风
爱听歌凤灵
adcffgg
heekkll
小荷才露尖尖角
然宝
My_magnum_opus
dghq
Kao
平淡金毛
DW
Hayat
皖公网安备34019202002308
